Mechanisms of hypertension: the expanding role of aldosterone.
暂无分享,去创建一个
[1] J. Connell,et al. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? , 2003, Hypertension.
[2] A. Náray-Fejes-Tóth,et al. sgk Is an Aldosterone-induced Kinase in the Renal Collecting Duct , 1999, The Journal of Biological Chemistry.
[3] M. Stowasser,et al. HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSION , 1994, Clinical and experimental pharmacology & physiology.
[4] S. Podolsky,et al. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. , 1983, The Journal of clinical investigation.
[5] T. MacDonald,et al. Potentially high prevalence of primary aldosteronism in a primary-care population , 1999, The Lancet.
[6] F. Cambien,et al. Genetic determination of plasma aldosterone levels in essential hypertension. , 1998, American journal of hypertension.
[7] J. Brown,et al. Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome. , 1972, Lancet.
[8] P. Padfield,et al. THE MYTH OF IDIOPATHIC HYPERALDOSTERONISM , 1981, The Lancet.
[9] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.
[10] W. Young. primary Aldosteronism: Update on Diagnosis and Treatment , 1997 .
[11] Jonathan S. Williams,et al. 50th anniversary of aldosterone. , 2003, The Journal of clinical endocrinology and metabolism.
[12] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[13] P. Komesaroff,et al. 6 Mineralocorticoid resistance , 1994 .
[14] W. Young,et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. , 2000, The Journal of clinical endocrinology and metabolism.
[15] A. Davignon,et al. Human arterial hypertension: a state of mild chronic hyperaldosteronism? , 1956, Science.
[16] X. Jeunemaître,et al. Altered Adrenal Sensitivity to Angiotensin II in Low-Renin Essential Hypertension , 1999 .
[17] Yanbin Dong,et al. Regulation of the epithelial sodium channel by accessory proteins. , 2003, The Biochemical journal.
[18] N. Hollenberg,et al. The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man. , 1975, Clinical science and molecular medicine.
[19] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[20] P Whelton,et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.
[21] F. Soubrier,et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. , 1999, Hypertension.
[22] A. C. Maiyar,et al. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum , 1993, Molecular and cellular biology.
[23] H. Schunkert,et al. Relation between dehydroepiandrosterone sulfate and blood pressure levels in a population-based sample. , 1999, American journal of hypertension.
[24] N. Kaplan. The steroid content of adrenal adenomas and measurements of aldosterone production in patients with essential hypertension and primary aldosteronism. , 1967, The Journal of clinical investigation.
[25] T. Mckenna,et al. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. , 1991, The Journal of clinical endocrinology and metabolism.
[26] P. White,et al. Haplotype analysis of CYP11B2. , 1995, Endocrine research.
[27] F. Messerli,et al. Response of several adrenal steroids to ACTH stimulation in essential hypertension. , 1977, The Journal of clinical endocrinology and metabolism.
[28] J. S. Janicki,et al. Remodeling of the rat right and left ventricles in experimental hypertension. , 1990, Circulation research.
[29] M. Stowasser. New Perspectives On The Role Of Aldosterone Excess In Cardiovascular Disease , 2001, Clinical and experimental pharmacology & physiology.
[30] X. Jeunemaître,et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. , 1998, Hypertension.
[31] C. Gomez-Sanchez,et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. , 2000, The Journal of clinical endocrinology and metabolism.
[32] W. Young,et al. Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. , 2002, Endocrinology and metabolism clinics of North America.
[33] C. Edwin,et al. Effect of adrenal suppression with dexamethasone in essential hypertension. , 1979, The Journal of clinical endocrinology and metabolism.
[34] J. Lalouel,et al. A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension , 1992, Nature.
[35] P. White,et al. Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). , 1989, The Journal of biological chemistry.
[36] D. Housman,et al. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. , 1987, Science.
[37] J. Connell,et al. Effects of ACTH and Cortisol Administration on Blood Pressure, Electrolyte Metabolism, Atrial Natriuretic Peptide and Renal Function in Normal Man , 1987, Journal of hypertension.
[38] P. White. Steroid 11β-Hydroxylase Deficiency and Related Disorders , 2001 .
[39] P. Hopkins,et al. Evidence for Heritability of Non‐modulating Essential Hypertension , 1989, Hypertension.
[40] J. Connell,et al. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. , 2002, The Journal of clinical endocrinology and metabolism.
[41] B. Pitt,et al. EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 2003 .
[42] H. Garty,et al. Epithelial sodium channels: function, structure, and regulation. , 1997, Physiological reviews.
[43] J. Connell,et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. , 1999, Hypertension.
[44] A. Neville,et al. The structure of the human adrenal cortex in health and disease , 1972 .
[45] C Clyne,et al. Differential regulation of aldosterone synthase and 11beta-hydroxylase transcription by steroidogenic factor-1. , 2002, Journal of molecular endocrinology.
[46] P. White. Disorders of aldosterone biosynthesis and action. , 1994, The New England journal of medicine.
[47] T. Symington. Functional pathology of the human adrenal gland , 1969 .
[48] J. Horisberger. Amiloride-sensitive Na channels. , 1998, Current opinion in cell biology.
[49] D. Rotin. Regulation of the epithelial sodium channel (ENaC) by accessory proteins , 2000, Current opinion in nephrology and hypertension.
[50] T. MacDonald,et al. The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? , 2002, Journal of hypertension.
[51] J. Conn. PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION. , 1964, JAMA.
[52] T. Aizawa,et al. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? , 1991, Cardiology.
[53] J. Connell,et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects , 2001, Clinical endocrinology.
[54] W L Miller,et al. Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.
[55] J. Melby,et al. Alterations in aldosterone secretion and metabolism in low renin hypertension. , 1990, The Journal of clinical endocrinology and metabolism.
[56] J. Connell,et al. 11 beta-Hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension? , 1996, Endocrine research.
[57] T. Kurtz,et al. Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat , 1993, Nature Genetics.
[58] P. Hopkins,et al. Familial Aggregation of Low-Renin Hypertension , 2002, Hypertension.
[59] D. Tosteson,et al. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. , 1980, The New England journal of medicine.
[60] L. Opie,et al. The aldosterone/renin ratio as a screening test for primary aldosteronism. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[61] J. H. Laragh,et al. Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension. , 1984, The American journal of medicine.
[62] W. Oelkers. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. , 1985, Acta endocrinologica.
[63] J. Whitworth,et al. Cushing, cortisol, and cardiovascular disease. , 2000, Hypertension.